Cansortium Stock Market Value
| CNTMF Stock | USD 0.08 0.01 9.30% |
| Symbol | Cansortium |
Cansortium 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cansortium's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cansortium.
| 11/12/2024 |
| 12/12/2024 |
If you would invest 0.00 in Cansortium on November 12, 2024 and sell it all today you would earn a total of 0.00 from holding Cansortium or generate 0.0% return on investment in Cansortium over 30 days. Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in the United States More
Cansortium Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cansortium's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cansortium upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 46.67 | |||
| Value At Risk | (11.76) | |||
| Potential Upside | 12.5 |
Cansortium Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cansortium's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cansortium's standard deviation. In reality, there are many statistical measures that can use Cansortium historical prices to predict the future Cansortium's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.42) | |||
| Total Risk Alpha | (2.30) | |||
| Treynor Ratio | 0.1979 |
Cansortium Backtested Returns
Cansortium secures Sharpe Ratio (or Efficiency) of -0.1, which signifies that the company had a -0.1% return per unit of risk over the last 3 months. Cansortium exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cansortium's Mean Deviation of 5.76, risk adjusted performance of (0.08), and Standard Deviation of 8.28 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -4.99, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Cansortium are expected to decrease by larger amounts. On the other hand, during market turmoil, Cansortium is expected to outperform it. At this point, Cansortium has a negative expected return of -0.86%. Please make sure to confirm Cansortium's value at risk, as well as the relationship between the accumulation distribution and day typical price , to decide if Cansortium performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.01 |
Very weak reverse predictability
Cansortium has very weak reverse predictability. Overlapping area represents the amount of predictability between Cansortium time series from 12th of November 2024 to 27th of November 2024 and 27th of November 2024 to 12th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cansortium price movement. The serial correlation of -0.01 indicates that just 1.0% of current Cansortium price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.01 | |
| Spearman Rank Test | 0.58 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Cansortium lagged returns against current returns
Autocorrelation, which is Cansortium otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cansortium's otc stock expected returns. We can calculate the autocorrelation of Cansortium returns to help us make a trade decision. For example, suppose you find that Cansortium has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Cansortium regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cansortium otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cansortium otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cansortium otc stock over time.
Current vs Lagged Prices |
| Timeline |
Cansortium Lagged Returns
When evaluating Cansortium's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cansortium otc stock have on its future price. Cansortium autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cansortium autocorrelation shows the relationship between Cansortium otc stock current value and its past values and can show if there is a momentum factor associated with investing in Cansortium.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Cansortium OTC Stock
Cansortium financial ratios help investors to determine whether Cansortium OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cansortium with respect to the benefits of owning Cansortium security.